Protein phosphatase 6 regulates metabolic dysfunction-associated steatohepatitis via the mTORC1 pathway
{{output}}
Background & aims: Metabolic dysfunction-associated steatohepatitis (MASH) is a serious chronic liver disease with limited therapies. Although fibroblast growth factor 21 (FGF21) analogs have shown promising therapeutic benefits ... ...
